Vaxcyte, Inc. PCVX Short- and long-term operating lease liabilities
Short- and long-term operating lease liabilities at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s short- and long-term operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s short- and long-term operating lease liabilities?
- Vaxcyte, Inc. (PCVX) reported short- and long-term operating lease liabilities of -$1.29M in Q1 2026.
- How has Vaxcyte, Inc.'s short- and long-term operating lease liabilities changed year-over-year?
- Vaxcyte, Inc.'s short- and long-term operating lease liabilities decreased by 108.0% year-over-year, from $16M to -$1.29M.
- What is the long-term trend for Vaxcyte, Inc.'s short- and long-term operating lease liabilities?
- Over 2 years (2022 to 2024), Vaxcyte, Inc.'s short- and long-term operating lease liabilities has grown at a 503.2% compound annual growth rate (CAGR), from $1.15M to $41.89M.